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Summary 
Human CD3-16 +  56 § natural killer (NK) cells have been shown to display a donaUy distributed 
ability  to recognize major histocompatibility complex (MHC) class I alleles. Opposite to T 
lymphocytes, in NK cells, specific  recognition of MHC class I molecttles appears to induce inhibition 
of cytolytic activity and, thus, to protect target cells. Since a precise correlation has been established 
between the expression of the NK-specific GL183 and EB6 surface molecules (belonging to the 
novel p58 molecular family) and the specificity of NK clones, we analyzed whether p58 molecules 
could function as receptors for MHC in human NK cells. NK clones displaying the previously 
defined "specificity 2" and characterized by the GL183 +  EB6 + phenotype, specifically recognize 
the Cw3 allele and thus fail to lyse the Fc"/R + P815 target cells transfected with Cw3. On the 
other hand, NK clones displaying "specificity 1" and expressing the GL183-EB6 + phenotype 
failed to lyse Cw4 + target cells. Addition of the F(ab')2 fragments of either GL183 or EB6 mAb 
as well as the XA141 mAb of IgM isotype (specific for the EB6 molecules) completely restored 
the lysis of Cw3-transfected  P815 cells by the Cw3-specific NK clones EX2 and EX4. Similarly, 
both the entire EB6 mAb, its F(ab')z fragment and the XA141 mAb reconstituted the lysis of 
C1R,  a Fc'yR-  target cell expressing Cw4 as the only serologically detected class I antigen. 
Thus, it appears that masking of different members of p58 molecules prevents recognition of 
"protective" MHC class I alleles and thus the delivering of inhibitory signals. Further support 
to the concept that p58 molecules represent a NK receptor delivering a negative signal was provided 
by experiments  in which the entire anti-p58  mAbs (of IgG isotype) could inhibit the lysis of 
unprotected Fc'yR + P815 target cells, thus mimicking the inhibitory effect of MHC class I 
molecules. 
ecent data have substantially modified the general con- 
cept that human CD3- CD16 +  CD56 + NK cells (1, 
2) represent a homogeneous cytolytic lymphoid population 
displaying nonspecific, non-MHC-restricted functions. Thus, 
it has been shown that NK cells are capable of specific func- 
tions since they can discriminate among different normal al- 
logeneic target cells (3, 4). This ability is clonally distributed 
as different NK clones derived from single individuals dis- 
play unique cytolytic patterns against allogeneic target cells 
(5-7). Thus, five distinct groups of alloreactive clones (each 
displaying  a different  specificity) have been identified  (7). 
Genetic analysis (6, 7) and the use of cell transfectants  (8) 
indicated that the target molecules recognized by NK clones 
are represented,  at least in some instances, by HLA class I 
alleles (8-11). Whereas specific recognition of MHC mole- 
cules by alloreactive cytolytic T lymphocytes leads to trig- 
gering of their cytolytic function, in the case of NK lym- 
phocytes,  a given HLA allele (Cw3) was found to confer 
specific protection from lysis by a group of NK clones dis- 
playing a defined specificity (specificity 2) (8, 9). These data 
imply that NK cells are equipped with clonally distributed 
receptors specifically  involved in MHC class I recognition (8, 
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tection from lysis,  could be that binding of NK-receptors 
(NK-R) to MHC molecules expressed on target cells, would 
induce a negative signal to the NK cells (9,  12, 13). A pos- 
sible candidate to act as an NK-R for MHC is represented 
by the NK-specific p58 molecular family (5,  9,  14). Single 
members of this family have been identified by the GL183 
(14) and EB6 (5) mAbs, and were found to be confined to 
subsets of human NK cells. The combined use of these mAbs 
allowed the identification of four different NK subsets (5). 
That the p58 molecular family may be involved in MHC rec- 
ognition has been suggested by the strict correlation existing 
between the allospecificities  recognized by NK clones and 
their GL183/EB6 surface phenotype (5, 7, 9). In addition, 
the possibility that p58 molecules could function as NK-R 
was suggested by their ability to regulate the cytolytic func- 
tion of human NK cells against different allogeneic tumor 
target cells (5,  14). 
In this report we show that mAb-mediated masking of 
p58 molecules leads to restoration of lysis of MHC class I 
protected  target  cells  by  NK  clones  recognizing  defined 
(allo)specificities. This strongly suggests that anti-P58 mAbs 
are specific for NK-R involved in specific MHC class I rec- 
ognition. 
Materials and Methods 
Antibodies.  mAbs OKT3 (IgG2a anti-CD3; Ortho Pharmaceu- 
ricals, Raritan, NJ), JT3A (IgG2a anti-CD3), HP2.6 (IgG2a anti- 
CD4), B9.4 (IgG2b anti-CD8, GL183 (IgG1 anti-p58), EB6 (IgG1 
antip58), XA-141 (IgM anti-p58), KD1 (IgG2a anti-CD16), c127 
(IgG1 anti-CD16),  c288 (IgG1 anti-CD16),  K218 (IgG1 anti- 
CD56),  and A6-220 (IgM anti-CD56),  were used in this study. 
Cloning  of  CD3-16+56 + Lyraphocytes.  PBL  derived  from 
normal donors were isolated on Ficoll-Hypaque gradients and cells 
were then incubated with a mixture of OKT3, HP2.6, and B9.4 
mAbs followed by treatment with rabbit C for 1 h at 37~  as pre- 
viously described (3, 6). Viable cells were isolated and cloned under 
limiting dilution conditions in the presence  of irradiated feeder  cells, 
0.1% (vol/vol) PHA (Gibco Ltd.,  Paisley, Scotland), and exoge- 
nous IL-2 (rIL-2, Cetus Corp., Emeryville, CA), as previously de- 
scribed for both T and NK cell cloning (7,  15,  16). 
Cytolytic Assays.  The cytolytic activity of cloned NK ceils was 
assessed in a 4-h SlCr-release assay in which effector cells were 
tested against the murine P815 cell line (either transfected with 
the Cw3 gene or untransfected) (8) or the CIR human cell line 
(17). In other experiments, cloned NK cells were used against a 
series of human or routine tumor target ceils including IGROV, 
Raji, U937,  M12, and P3U1. 
All these target cells were used at 5  x  103/well and the final 
E/T ratio is indicated in the text. Percent specific  lysis was deter- 
mined as previously described (3, 6). mAbs were added at the onset 
of the cytolytic assay before adding target cells. The mAb concen- 
trations used in the various assays are indicated in the text. 
Flow Cytofluorimetric Analysis.  Cells  were stained with the ap- 
propriate mAb followed  by fluoresceinated  goat anti-mouse Ig. Con- 
trol aliquots were stained with the fluoresceinated reagent alone. 
All samples were then analyzed on a flow cytometer (FACStar  | 
Becton Dickinson & Co., Mountain View, CA) gated to exclude 
nonviable cells (7). 
Preparation of F(at/)z Fragments of Ann'-p58 mAbs.  This method 
was previously  described  (14). Briefly,  2 ml of DEAE-Sephacel  (Phar- 
macia LKB Biotechnology,  Uppsala, Sweden)-purified  IgG1 GL183 
mAb (1 rag/m1) was dialyzed  overnight against acetate  buffer (0.1 M, 
pH 3.8). Next, the mAb was digested with 50/zg of pepsin (Wor- 
thington Biochemical Corp., Freehold, NJ) for 6 h at 370C, after 
which the digestion was stopped with 3 M Tris-HCl, pH 8.6, and 
by placing the reaction mixture on ice. This mixture was dialyzed 
overnight in 50 mM Tris-HC1, pH 8, and applied to a 10-ml DEAE- 
Sephacd column. 1-ml fractions were collected and assayed spec- 
trophotometrically at 280 nm and by 7 and 11% SDS-PAGE  under 
reducing and nonreducing conditions, respectively. 
Results and Discussion 
Effect of Anti-p58 F(at/)2 on the Lysis of Cw3.transfected 1>815 
Cells by NK Clones Displaying Specificity 2.  The murine P815 
target ceUs are efficiently lysed by human NK dones regard- 
less of their (allo)specificity (5, 8). However, transfection of 
P815 cells with the human class I allele Cw3 has been shown 
to confer selective protection from lysis by NK clones dis- 
playing specificity 2 (8, 9). P815 cells transfected with other 
class I alleles including A2, A3, and A24 were not protected 
from lysis by this group of dones (8, 9). In addition, other 
groups  of clones  (i.e.,  displaying  specificities  other  than 
specificity 2) efficiently lysed Cw3-transfected P815 cells. As 
previously shown, all NK clones displaying specificity 2 are 
characterized by  the  simultaneous expression  of the  two 
members of the p58 molecular family defined by the GL183 
and EB6 mAbs (7, 9). We assessed whether the p58 mole- 
cules expressed by these clones played a role in the recogni- 
tion of the Cw3 allele in P815 transfectants. To this end, we 
used the F(ab')2 fragments of the mAbs GL183  and EB6. 
The use of F(ab')2 fragments was required since P815 target 
cells express Fc3,R which efficiently bind murine antibodies 
of the ~/1 isotype, such as GL183  and EB6 mAbs (5,  14). 
As shown in Fig. 1, clones EX2 and EX4, both expressing 
the GL183+EB6 + surface phenotype and displaying specifi- 
city 2, were highly cytolytic against untransfected P815 cells 
(Fig.  1, B and F) In agreement with our previous reports 
(8, 9), P815 cells transfected with Cw3, but not with other 
dass I aUeles, were resistant to lysis (Fig.  1, A and E). Addi- 
tion  of F(ab')2  fragments of either  GL183  or  EB6  mAb 
resulted in lysis of Cw3-transfected P815 ceils that was com- 
parable in magnitude to that of untransfected cells by the 
same NK dones (Fig.  1, A  and E). That this phenomenon 
was not due to an anti-p58 F(ab')2-induced stimulator,/effect 
was shown by control experiments in which lysis of untrans- 
fected P815 cells was not modified by the addition of the anti- 
p58 F(ab')2 fragments (Fig.  1, B and F,  14).  Note that,  as 
previously described (5,  14),  the use of the entire anti-p58 
mAbs strongly inhibited the lysis of untransfected P815 calls 
(Fig.  1, D  and H).  Accordingly, unlike the correspondent 
F(ab')2 fragments, the entire mAb did not restore lysis of 
Cw3-transfected P815 cells (Fig.  1,  C  and G).  Fig.  1 also 
shows  that  the control done EX10  (GL183-EB6+),  dis- 
playing specificity 1, (5, 7, 9) lysed both P815 and P815 trans- 
fected with Cw3 (Fig. 1, I and L). Whereas the F(ab')2 frag- 
ments of anti p58 mAb had no effect (Fig.  1, I and L), the 




t  j" 
0 
o  I 
o  o,5 
,oo  IE 
5o  0 
o  !  ! 
o  05 
10o 
o  o!~ 
P815  P815  P815 
CW3+ 
i,  i 
I  I  I  / 
o  05  o  o.5  o  05 
i 
I  I  I  I  I  I 
o  0.5  o  0.5  o  o.5 
8~8  = 
I  I  I  I  I  I 
o  05  o  05  o  0.5 
mAb  concentration added to the cytolytlc  assay (l.tglml) 
￿9  EB6 F(ab')~  O  GL183  F(ab')2  ￿9  EB6  [] GLI83 
CLONE  EX 2 
GL183*  EB6+ 
CLONE  EX 4 
GLIB3+  EB6+ 
CLONE  EX  10 
GL183- EB6+ 
Figure  1.  Reconstitution  of cytolytic activity by anti-p58 
F(ab')z  fragments  in  CD3-16 +  NK  clones  displaying 
specificity 2. Clones EX2 (A-D) and EX4 (E-H), character- 
ized  by the GL183+EB6 +  phenotype,  are  specifically in- 
hibited by the Cw3-transfected  P815 cells (.4, C and E, C, 
respectively).  Clone EXl0  (I-N) expressing  the GL183- 
EB6 + phenotype is inhibited by Cw4 + but not by Cw3 + 
target cells (I, M) (see text). The various clones were tested 
either in the presence or absence of anti-p58 mAbs (EF--O, 
GL183, H,  EB6) or of their F(ab')z fragments (O---O, 
GL183, ~-O,  EB6) against SlCr-hbeled P815 cells or P815 
transfected with the Cw3 gene. The E/T ratio was, in all 
instances, 10:1, and the various mAbs were added at the onset 
of the cytolytic assay (final concentration, 0.5 #g/ml). 
entire EB6 mAb completely abrogated lysis of both target 
cells (Fig.  1, M and N). Although not shown, the XA141 
mAb, which reacts with the same p58 molecule recognized 
by the EB6 mAb but is of IgM isotype, could restore lysis 
of Cw3-protected cells. In addition, since IgM antibodies do 
not bind to FcR expressed by P815 cells, the XA141  mAb 
could not inhibit cytolysis in the redirected killing assay (Fig. 
2). Controls included mAbs K218 (anti-CD56, IgG1)  and 
A6-220 (anti-CD56, IgM). These mAbs neither restored lysis 
of Cw3-transfected target cells (data not shown) nor inhibited 
cytolytic activity in the redirected killing assay (see Fig. 2, 
B). Taken together, these data indicate that masking of p58 
molecules by F(ab')2 fragments, leads to restoration of lysis 
of target cells protected by appropriate class I alleles. On the 
other hand, the crosslinking induced by the entire anti-p58 
mAb,  in  the  presence  of  the  Fc~R +  P815 target  cells, 
resulted in inhibition of lysis (Fig. 1, D, H, and N) (5, 14). 
These data strongly suggest that both p58 molecules defined 
by GL183 and EB6 mAb may be part of a receptor specific 
for a given class I allele (i.e., Cw3) in NK clones displaying 
specificity 2. Along this line,  the inhibitory effect induced 
by entire anti-p58 mAbs (of IgG isotype) on the lysis of un- 
protected P815 cells can be interpreted as an antigen-like effect 
mimicking the binding of the NK-R to protective class I 
MHC alleles. 
Effect of  Anti-p58 mAbs on the L ysis of the Cw4 + C1R Cell 
Line by NK Clones Displaying Speci~city I.  In previous reports 
(5,  7), we demonstrated that, in most individuals, expres- 
sion of the GL183-EB6 + surface phenotype correlates with 
the previously defined specificity 1. In the case of clones dis- 
playing this specificity, a number of experimental evidences 
suggested that Cw4 or related C alleles (Cw2 and Cw6) (8, 
18) could represent protective elements when expressed by 
target cells. Thus, in representative families, a cosegregation 
could be determined between the character resistance to lysis 
(by NK clones with specificity 1) and expression of the Cw4 
allele (6, 7). In addition, analysis of cell variants suggested 
that the loss of expression of Cw4 is associated with the de 
novo acquisition of susceptibility to lysis by clones  with 
specificity 1 (in the same experiments, the loss of Cw3 led 
to susceptibility to lysis by clones with specifidty 2) (8). There- 
fore, we assessed whether p58 molecules could function as 
putative receptors for MHC molecules also in GL183-EB6 § 
NK dories displaying specificity  I  (7). 
Table 1 shows that the GL183-EB6 + NK clones EX10 
and CEG53 failed to lyse the mutant B cell line C1R, which 
express Cw4 as the only serologically detected class I antigen 
(17). This target cell, was resistant to anti-1 NK clones (EX10 
and CEG53) whereas it was efficiently killed by NK clones 
displaying specificity 2 such as clones EX2 and EX4 (Table 
1), as well as by clones with other specificities (7, 8) (data 
not shown). On the other hand, the GL183-EB6 + clones 
EX10 and CEG53 displayed a strong cytolytic activity against 
a series of target cells negative for Cw4 or related C alleles 
(Cw2 and Cw6; 18) including Cw3-transfected or untrans- 
fected murine P815 cells (Fig.  1, I and L) and several EBV- 
transformed human cell lines (data not shown). Addition of 
either the entire EB6 mAb (or its F[ab']2 fragment; Table 
1) resulted in the de novo appearance  of a strong cytolytic 
activity of clones EX10 and CEG53 against C1K target cells. 
It should be noted that, unlike P815 cells, C1K cells do not 
function in a redirected  killing assay with appropriate mu- 
rine mAbs (e.g., anti-CD16 mAbs of'y1 or ~,2a isotype, data 
not shown). As a consequence, the entire EB6 mAb can only 
599  Moretta  et aL Table  1.  Effect of Anti-p58  mAbs on the Cytolytic Activity of GLI83-EB6 + NK Clones Displaying Specificity I  against the Cw4 +, 
C1R  Target Cells 
Antibody added to  the cytolytic assays 
Clone*  Phenotype  None  EB6  EB6  F(ab')2  XA141  K218 
EX10  GL183 -  EB6  §  811  92  75  89  6 
CEG  53  GL183-EB6 §  10  87  71  78  11 
EX  2  GL183+EB6 +  48  44  46  ND  49 
EX  4  GL183+EB6 +  67  60  63  ND  65 
* Clones EX 10 and CEG 53 are characterized by the previously described  specificity 1 whereas clones EX 2 and EX 4 recognize the specificity 2. 
* stCr-labeled C1R target cells are protected against the lysis mediated by clones displaying specificity 1 but not against dones displaying specificity 2. 
s In these experiments mAbs (0.5/zg/ml) were added at the onset of the cytolytic assay. EB6 (IgG1 anti p58 molecule),  XA141 (IgM anti-p58, 
EB6 molecule), and K218 (IgG1 anti-CD56). 
II Data are expressed  as a percent specific slCr-release as previously described (15). 
bind to the effector cells and prevent the interaction between 
P58 and MHC molecules. 
Thus, also in the case of GL183-EB6 +, NK clones dis- 
playing specificity 1, masking of p58 molecules restores lysis 
of protected target cells. It is noteworthy that the GL183- 
EB6 + clones were strongly inhibited in their ability to lyse 
the Fe3dk  + P815 cells by entire EB6 mAb (Fig. 1 N and Fig. 
2 B [5]). Thus again, the mAb-induced crosslinking of p58 
molecules (which occurs with target cells binding murine 
mAbs via surface Fc3,R) resulted  in an antigen-like  effect 
mimicking the interaction between the NK receptor and pro- 
tective MHC molecules. No such effect occurred when ei- 
ther the F(ab')2 fragment of EB6 mAb (Fig. 1 L) or the IgM 
mAb XA141 (specific  for the EB6-defined p58 molecule) were 
used (Fig. 2 B). As shown in Fig. 2 A and Table 1, the XA141 
mAb could restore  the lysis of CIR target ceils by done 
CEG53, in a manner similar to EB6 mAb. Fig. 2 also shows 
that the amount of EB6 mAb needed for masking p58 mole- 
cules is higher than that required for inducing an inhibitory 
effect in a redirected killing assay. Similar differences in mAb 
concentrations required for triggering (in redirected killing 
assay) or masking have been previously detected in cytolytic 
T  cells using anti-TCIL mAbs (16, 19). 
Taken together, these data strongly suggest that the p58 
molecules are directly involved in the mechanism of specific 
MHC recognition by human NK cells. Thus they may be 
part of NK receptors,  different in different groups of NK 
clones, which mediate specific  binding to distinct MHC class 
I alleles. To explain the MHC class I recognition by NK cells, 
two alternative  hypotheses  have been considered:  (a)  the 
delivering of a negative signal to NK cells after interaction 
with protective MHC class I molecules (9, 13, 20, 21); and 
(b) the "target interference" hypothesis postulating that dass 
I antigens and/or their associated peptides sterically mask rec- 
ognition of an NK target structure (responsible for NK cell 
activation) on the target cells (9, 20, 21). Our data are com- 
patible with the hypothesis that the protective class I alleles, 
upon interaction with appropriate  NK receptors, deliver a 
negative signal that prevents lysis of protected target cells (9, 
12,  13). In line with this concept, our data  suggest  that 
masking of the putative NK receptor prevents binding of the 
receptor itself to the specific MHC molecules expressed on 
target cells, thus inhibiting the delivering of the negative signal. 
According to the hypothesis that P58 molecules may be part 
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Figure  2.  Reconstitution of cytolytic activity or antigen-like effect ex- 
erted by anti-p58 mAbs in CD3-16 + clones displaying specificity 1. Clone 
CEG53 (GL183-EB6 +), which is specifically inhibited by target calls ex- 
pressing Cw4 allde, was assessed for cytolytic activity against the Cw4 + 
cell line C1R in the presence of graded amounts of EB6 (o---o, IgG1) 
or XA-141 (~--~,  IgM) mAbs (both specific for the same p58 mole- 
cule).  Control antibodies included the anti-CD56 mAb K218  (A---~, 
IgG1).  (B) The same done was assessed against the Fc'yR  + murine cell 
line P815 (which does not express Cw4). Note that in this redirected killing 
assay the IgG, but not the [gM mAb directed to the p58 molecule,  in- 
hibited the cytolytic activity. 
600  Natural Killer Receptors for Major Histocompatibility Complex of a NK receptor complex, it is likely that these molecules 
represent the actual specific receptor responsible for the rec- 
ognition of different MHC alleles. On the other hand, it is 
unlikely that the p58 molecules may function as coreceptor 
structures (such as CD4 or CD8 in T  lymphocytes). This 
is suggested by the finding that anti-p58 mAbs, in addition 
to their ability to interfere with the negative signal induced 
by protective MHC elements, also mimic the functional effect 
of protective MHC molecules in unprotected target cells (such 
as  the Fc~R +  P815  cells)  (Fig.  3).  Further evidence sup- 
porting this hypothesis is provided by the precise correlation 
existing between the GL183/EB6 surface phenotype of NK 
clones and their specificity for different class I alleles (5, 7, 9). 
Thus,  interaction between MHC  class I  molecules and 
specific receptors is a crucial event in the function of both 
cytolytic T lymphocytes and NK cells. However, whereas in 
T cells such interaction results in triggering of cytolysis, in 
NK cells it would result in inhibition. These opposite func- 
tional effects also occur when anti-receptor mAbs are used. 
Anti-TCR mAbs (anti-or3 or -y//$) have been shown to 
trigger the cytolytic function of CTLs in a redirected killing 
assay against P815 (16), thus mimicking the effect of MHC 
(e.g., alloantigen) recognition (this phenomenon is commonly 
referred to as an "antigen-like effect" [22, 23]).  On the con- 
trary, under the same experimental conditions, anti-p58 mAbs 
inhibit the cytolytic activity of NK cells,  thus mimicking 
the  protective effect of MHC  molecules,  mAb-mediated 
masking of TCR prevents MHC recognition and T cell-medi- 
ated specific cytolysis (24).  On the other hand, masking of 
p58 molecules would prevent MHC recognition and delivering 
of the negative signal (i.e., it reconstitutes target cell lysis). 
Regarding  the possible molecular structure of the NK 
receptor for class I molecules, a likely interpretation is that 
two members belonging to the p58 family compose a surface 
heterodimer which dictates the specificity for given class I 
alleles. In accordance with this interpretation, in GL183 +  / 
EB6 + clones, mAbs directed to either one of the p58 chains 
restored lysis of protected target cells. In addition, the finding 
that  EB6+/GL183 -  clones  display  an  MHC  specificity 
different from double positive clones (5, 7, 8) can be inter- 
preted by the existence, in these clones, of a heterodimer com- 
posed by the EB6 molecule and a still undefined p58 chain 
(EB6+/x+).  According to  this  interpretation,  EB6  mole- 
cules, possibly existing also in uncomplexed form, would not 
be able to recognize specific class I molecules. It is of note 
that recent data indicate that indeed, in double positive clones, 
GL183 and EB6 molecules are physically and functionally as- 
sociated (Moretta, A., M. Vitale, C. Bottino, R. Augugliaro, 
E. Ciccone, and L. Moretta, manuscript submitted for pub- 
lication. 
We previously showed that appropriate anti-p58 mAbs could 
increase the lysis mediated by NK clones only against certain 
human tumor target cells.  For example, the ovarian carci- 
noma cell line IGROV was relatively resistant to GL183 +, 
EB6 + clones displaying specificity 2 (14). Addition of GL183 
mAb (or the corresponding F(ab')2 fragment) resulted in a 
remarkable increase of lysis (note that IGROV cells do not 
express Fc3'R and thus are unable to function in redirected 
killing in the presence of appropriate murine mAbs; Table 
2). On the other hand, IGROV cells were highly susceptible 
to lysis by NK clones expressing different GL183/EB6 pheno- 
types (and thus different specificities). A likely interpretation 
of these data can be that IGROV cells express  a protective 
class I allele specifically recognized by GL183+/EB6 + clones. 
Table  2.  Effect of Anti-p58 mAbs on the Cytolytic Activity of GL183 +, EB6 + Clones against Human or murine  Tumor Cells 
~  Specific StCr-release in the presence of the following nlAbs 
KD1  c127  c288  GL183  EB6 
Target  (anti-CD16)  (anti-CD16)  (anti-CD16)  (anti-p58)  (anti-p58) 
Clone  cells  None  IgG2a  IgG1  IgG1  IgG1  IgG1 
134T49"  IGROV  7.2*  6.4  8.6  9,8  75.5  63.4 
F6.1  IGROV  11.3  ND  10.1  ND  68.4  51.3 
134T49  Raji  12.9  10.2  13.4  12.6  71.6  56.8 
F6.1  Raji  13.4  10,7  12.8  18.5  83.1  63.4 
134T49  U937  18.6  68.4  22.3  16.4  78.1  72.5 
F6.1  U937  19.3  89.8  29.4  19.4  93.2  80.4 
134T49  P815  36.4  89.6  85.2  82.2  3.4  3.7 
F6.1  P815  45.6  98.3  91.4  ND  7.8  9.1 
* Clones 134T49 and F6.1, which were assessed  for cytolytic  activity, were GL183+EB6  +  . The E/T ratio in this assay was 2:1 against the murine 
P815 cell line and 5:1 against the three different  human cell lines. 
* The various mAbs were added at the onset of the cytolytic  assay at a final dilution of 0.5 #g/ml. 
601  Moretta  et al. In this context, IGROV cells, different from K562, constitu- 
tively express HLA dass I antigens codified by the C locus 
(Ciccone, E., unpublished data). 
In addition, we showed (5, 14) that in murine tumor target 
cells expressing surface Fc~R, the anti-p58 mAbs had an op- 
posite effect (i.e., they induced inhibition of lysis). These mu- 
fine target cells are effidently lysed in a redirected killing assay 
in the presence of anti-CD16 mAbs of IgG isotype. For ex- 
ample, the P815 cell line has been described to express FcR 
for IgG1,  IgG2a, and IgG2b (25).  The P815 cells used in 
our study expressed receptors for (at least) IgG1 and IgG2a 
as shown by the effect in redirected killing assays of anti-CD16 
mAbs belonging to these subclasses (Table 2). Although not 
shown, NK-mediated lysis of Fc~/R-  murine target cells 
was neither inhibited nor incremented by anti-p58 mAbs. 
In the case of human tumor target cells, the functional 
effect of anti-p58 mAbs apparently did not seem to correlate 
with the surface expression of Fc'yR. For example, the lysis 
of both Raji (a Burkitt lymphoma) and U937 (a myelomono- 
cytic leukemia) by NK clones was increased in the presence 
of anti-p58 mAbs. However, as shown in Table 2, the Raji 
cells could not mediate redirected killing with murine mAbs 
since neither IgG2a nor IgG1 anti-CD16 mAbs could increase 
target cell lysis. Thus, operationally, Raji target cells func- 
tion as the FcyR- IGKOV cell line. In the case of the U937 
cell line available in our laboratory, an ef~dent redirected killing 
could be detected by using an anti-CD16 mAb of IgG2a iso- 
type. On the other hand, two different anti-CD16 mAbs of 
the IgG1 subclass (i.e., the same subclass of GL183 and EB6 
mAbs) failed to mediate a substantial redirected killing (Table 
2). It is noteworthy that both anti-CD16 mAbs of IgG1 iso- 
type could induce a strong increase of cytolytic activity against 
the Fcq,  R + murine P815 target cells. These data suggest a 
likely explanation for the increases of cytolytic activity de- 
tected against some FcyK + human tumor target cells. Thus, 
in the absence of an efficient crosslinking due to the low affinity 
of human Fcq,  K for murine IgG1 subclass, the increases of 
target cell lysis could again be consequent to a mAb-mediated 
masking of the NK receptor. In agreement with this interpre- 
tation, the XA141 mAb (IgM) also enhanced the lysis of the 
above  human  tumor  target  cells  by  GL183+EB6+  NK 
clones (data not shown). Finally, in some human tumor cell 
lines anti-p58 mAbs failed to induce an increase in cytolysis 
by double positive clones. In general, these tumor cells were 
already characterized by a high susceptibility to lysis by double 
positive clones. This may reflect the absence of expression 
of appropriate protective elements. As a consequence, these 
tumor cells would be similar to unprotected target cells such 
as the class I-negative K562 (14), the Cw4 + CIR (Table 1), 
or the Fc'yK-  murine cell lines. 
It is interesting that recent data on mice have suggested 
that the Ly49 antigen may be part of a NK receptor for MHC 
recognition (26). Expression of Ly49 molecules (or lack of 
expression) correlates with the specificity of murine NK cells 
for given MHC dass I alleles. Moreover, similar to our present 
data, F(ab')2 fragments of anti-Ly49 mAb reversed the inhi- 
bition  of  NK  cell-mediated  lysis  of  H2Dd-transfected 
Ivsis  inhibition of Iveie 
signal 
anti-p58 mAb added  I 
n.o..vo; 
signal 
inhibition of Ivsis 
I anti-p58 F(eb)2 added  I 
Ivsis 
= Cw3 allele  I-  = p58 molecule  ,~  = anti p58 mAb 
A  = anti p58 F(ab)2  ~  = Fcy receptor 
Figure  3.  Schematic representation of the effect of F(ab')2 fragments 
of anti-p58 mAbs on the lysis of class I protected target cells by alloreac- 
tire NK clones. The figure refers to a NK done displaying spedficity 2, 
as effector, and to the marine P815 cells transfected  (or not) with Cw3 
(i.e., the protective element for anti-2 dones), as targets. Since clones dis- 
playing spedficity 2 express two members of the p58 molecular family 
which are identified by the GL183 and by the EB6 mAbs, respectively, 
the corresponding F(ab')z fragments have been used. Note that anti-2 NK 
clones lyse untransfected  P815 cells (top left) but not I)815 that have been 
transfected with Cw3 (top right). Addition of F(ab')2 fragments of either 
GL183 or EB6 mAbs completely restores the tysis of Cw3-transfected cells 
(bottom right). These data can be interpreted as a masking effect of F(ab')2 
fragments preventing the interaction of p58 molecules with their Cw3 
ligand on target cells. Addition of the entire mAbs (which bind to FcyR  + 
P815 cells) results in inhibition of lysis of untransfected  cells (bottom left). 
Thus, the anti-p58 mAbs bound on target cells protect them from lysis, 
i.e., they mimic the effect of Cw3 molecules in delivering an inhibitory 
signal upon crosslinking of p58 molecules expressed by anti-2 NK clones. 
FcyR + target cells. However, at the present, Ly49 molecules 
do not resemble p58 for either biochemical characteristics or 
cellular distribution. In addition, it would be of interest to 
define whether mAbs to Ly49 molecules could mimic the 
effect of MHC molecules and deliver a negative signal in a 
redirected killing assay against Fcq,  R + target cells. 
Therefore, it appears that the cytolytic activity mediated 
by both human and mouse NK cells may be regulated by 
specific  receptors for MHC (p58 in human and Ly49 in mouse) 
which turn off the lytic machinery when engaged by appro- 
priate MHC alleles. Molecules different from these receptors 
would be responsible for NK cell activation (27-29) upon 
binding to appropriate ligands expressed on target cells. Ac- 
cording to this interpretation, the resistance to NK-mediated 
lysis of a given target cell would depend upon either the ex- 
pression of protective MHC dass I alleles or the lack of ap- 
propriate ligands for molecules involved in NK cell activation. 
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activation under physiological conditions? Since NK cells are 
continuously exposed to protective self-MHC class I mole- 
cules both in vivo and in vitro, one may speculate  that the 
negative signal delivered  via the NK-R could be polarized 
at the site of interaction between effectors and protected target 
cdls. Alternatively, the negative signal could function for a 
short period of time. Either one of these proposed mecha- 
nisms could explain why NK cells are able to lyse unprotected 
target  ceils  in  a  self-environment. Experiments  aimed at 
clarifying these mechanisms are in progress in our laboratory. 
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